Jeannie Rigby, chief executive of the charity Action Bladder Cancer UK, said: "Erdafitnib represents a new area of treatment for bladder cancer. "Bladder cancer has been badly neglected in terms ...

Jeannie Rigby, Chief Executive Officer at Action Bladder Cancer, said: “At Action Bladder Cancer UK, we are pleased to see the GALEASE urine biomarker test now being used in a clinical setting.

Jeannie Rigby, chief executive of the charity Action Bladder Cancer UK, welcomed the NICE decision. She said: "There are very few treatments available for bladder cancer in general, and ...

Jeannie Rigby, chief executive of the charity Action Bladder Cancer UK, welcomed the Nice decision. “There are very few treatments available for bladder cancer in general, and particularly for ...

Jeannie Rigby, chief executive of the charity Action Bladder Cancer UK, welcomed the Nice decision. “There are very few treatments available for bladder cancer in general, and particularly for people ...

chief executive of Action Bladder Cancer UK. "It's time that bladder cancer patients had some kind of new treatment available," she added. "We hope this is just the start of new hope for those ...

Jeannie Rigby, chief executive of the charity Action Bladder Cancer UK, welcomed the Nice decision. “There are very few treatments available for bladder cancer in general, and particularly for ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.

Jeannie Rigby, chief executive of the charity Action Bladder Cancer UK, welcomed the Nice decision. “There are very few treatments available for bladder cancer in general, and particularly for people ...